LAS VEGAS, Aug. 11, 2013 /PRNewswire/ -- Hemp, Inc. (OTC:
HEMP), a leader in the cannabis industry, has been on the forefront
of film production surrounding the hemp movement since its
inception. In fact, Hemp, Inc.'s production company, Marijuana Inc.
TV (www.MarijuanaInc.tv) was among the first to interview Chaz
Moore back in 2012 and give its support of medicinal marijuana
usage, along with its support of the Cash Hyde Foundation and
ongoing educational efforts, to not only educate the public on the
difference between hemp and marijuana, but also to educate the
public on the true medicinal value of cannabis.
(Logo:
http://photos.prnewswire.com/prnh/20121107/LA08133LOGO)
Chaz Moore is one of the few people
in the world diagnosed with the rare condition, Myoclonus
Diaphragmatic Flutter, and will be featured, again, on Dr.
Sanjay Gupta's documentary entitled,
"WEED", airing on CNN Sunday, August 11,
2013 at 8pm EST. (See Chaz
Moore's earlier interview with Hemp, Inc.'s Marijuana TV). After
high doses of ineffective Diazepam (commonly known as Valium),
Morphine and Xanax, and more, Chaz's father, Shan, after months of
research, decided to try medical marijuana. "It worked. I call it a
miracle drug," said Shan Moore.
And now a year later, "Hemp, Inc. salutes Dr. Gupta for his
research into the marijuana debate and his bravery in publicly
reversing his views," said CEO, Bruce
Perlowin. "We have long been traveling the country and
filming individuals such as Chaz
Moore, who have benefited from the use of medical marijuana
as well as the brave individuals who have been on the frontline of
the movement, like the legendary activist and advocate in the
cannabis reform movement, Steve
DeAngelo. I believe the star power of CNN's Chief Medical
Correspondent, Dr. Sanjay Gupta,
now, will really bring this message to the masses."
The truth is that medical marijuana and even the benefits of
Industrial Hemp have been systematically misleading. One key point,
Gupta brought up in a recent interview, and shedded light on, was
the distorted picture painted on medical marijuana. "The government
says there are no medical benefits, but then the United States, through its Department of
Health and Human Services, has a patent (U.S. Patent 6630507) on
marijuana as an anti-oxidant and neuroprotectant in the brain,"
says Dr. Sanjay Gupta.
The facts and research are clear and exact, however, most of the
public like Dr. Gupta was unaware of the research that has been
done over the last 5 decades.
"I believe in people and planet first, profit second (and doing
it this way actually ends up earning more profits). Hemp, Inc., as
the first publicly-traded company, has long since been a leader in
the industry," says Perlowin. "Industrial Hemp is off the charts in
its applications and potential. From textiles, to clothing, to
superfoods, hemp oil, protein, to paper, to building materials… the
possibilities are endless for this incredibly renewable,
sustainable, resource called Industrial Hemp."
Hemp, Inc.'s TRIPLE BOTTOM LINE
Hemp, Inc. (OTC: HEMP) seeks to benefit many constituencies, not
exploit or endanger any group of them. Thus, the publicly-traded
company believes in "upstreaming" of a portion of profit from the
marketing of their finished hemp goods back to its originator. By
Hemp, Inc. focusing on comprehensive investment results—that is,
with respect to performance along the interrelated dimensions of
people, planet, and profits— our triple bottom line approach can be
an important tool to support sustainability goals.
CONTACT:
phone: 1-877-221-8351
email: info@hemp.com
http://www.hemp.com
SOURCE Hemp, Inc.